A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp

NCT05387525 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

447

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratosis, Actinic

Interventions

DRUG: Tirbanibulin (Klisyri®) 10 mg/g ointment
DRUG: Diclofenac Sodium 3% Gel

Sponsor

Almirall, S.A.